Oxarol


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 63.8%
Hyperphosphataemia 11.3%
Psoriasis 6.1%
Adverse Event 4.7%
Diabetes Mellitus 3.8%
Gastritis 1.9%
Hyperlipidaemia 1.9%
Maternal Exposure During Pregnancy 1.9%
Arrhythmia 0.9%
Arthralgia 0.9%
Iron Deficiency Anaemia 0.9%
Peripheral Vascular Disorder 0.9%
Pruritus 0.9%
Hyperphosphatasaemia 63.2%
Supraventricular Tachycardia 10.5%
Bronchitis 5.3%
Drug Ineffective 5.3%
Maternal Exposure Timing Unspecified 5.3%
Pulmonary Oedema 5.3%
Renal Impairment 5.3%
Concomitant
Product Used For Unknown Indication 41.1%
Psoriasis 18.8%
Hyperphosphataemia 13.7%
Hyperparathyroidism Secondary 5.8%
Hypertension 4.2%
Prophylaxis 2.9%
Psoriatic Arthropathy 2.5%
Nephrogenic Anaemia 1.6%
Angina Pectoris 1.1%
Insomnia 1.0%
Pustular Psoriasis 1.0%
Diabetic Nephropathy 0.9%
Hepatitis C 0.8%
Gastric Ulcer 0.7%
Haemorrhage Prophylaxis 0.7%
Constipation 0.7%
Hyperuricaemia 0.6%
Gastritis 0.6%
Renal Failure Chronic 0.6%
Diabetes Mellitus 0.6%
Hepatic Function Abnormal 7.0%
Shunt Malfunction 7.0%
Nausea 6.5%
Traumatic Fracture 6.5%
Anaemia 6.0%
Angina Pectoris 5.6%
Putamen Haemorrhage 5.6%
Melaena 5.1%
Hyperparathyroidism Secondary 4.7%
Pneumonia 4.7%
Procedural Hypotension 4.7%
Subarachnoid Haemorrhage 4.7%
Vomiting 4.7%
Diverticulitis 4.2%
Gynaecomastia 4.2%
Lumbar Spinal Stenosis 4.2%
Syncope 4.2%
Constipation 3.7%
Gastric Ulcer 3.7%
Cerebral Infarction 3.3%

Drug Data